Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/52328
Conference/Presentation Title: | High-dose specific omega-3 polyunsaturated fatty acid increases plaque stability in tandem-stenosis ApoE-deficient mice fed high fat-diet. | Authors: | Dao T.;Thomas J.;Chen Y.-C.;Nicholls S. ;Bubb K. | Monash Health Department(s): | Cardiology (MonashHeart) | Institution: | (Dao, Thomas, Chen, Nicholls, Bubb) Victorian Heart Institute, Clayton, Australia | Presentation/Conference Date: | 21-Aug-2024 | Copyright year: | 2024 | Publisher: | Elsevier Ireland Ltd | Publication information: | Atherosclerosis. Conference: EAS 2024. Padova Italy. 395(Supplement 1) (no pagination), 2024. Article Number: 117742. Date of Publication: August 2024. | Journal: | Atherosclerosis | Abstract: | Background and Aims: Omega-3 polyunsaturated fatty acids have long been associated with cardioprotective benefits, including having anti-inflammatory and antioxidant effects. However, large-scale randomised-controlled cardiovascular outcomes trials have shown greatest benefit from treatment with high-dose, pure eicosapentaenoic acid (EPA), while high dose mixed omega 3 fatty acids do not appear to be effective in reducing major cardiovascular adverse events. We aimed to conduct a head-head comparison between treatment with EPA or docosahexanoic acid (DHA) in plaque development and vulnerability using a carotid artery plaque rupture-prone model in mice. Method(s): Apolipoprotein E (apoE)-/- mice were fed a high fat and high cholesterol diet from 8 weeks of age. After 6 weeks, mice underwent surgical implantation of dual ligatures 3 mm apart with 150 um diameter in the right common carotid artery to create turbulent blood flow, leading to the development of rupture-prone plaque. 3 weeks post surgery, daily treatment with high-dose EPA or DHA (600 mg/kg/day, oral) commenced. After 4 weeks of treatment, the diseased right carotid arteries and contralateral healthy left carotid arteries were isolated and frozen in OCT buffer. Arteries were then serially cryosectioned and stained with H&E or picrosirius red to determine the effect of omega-3 fatty acids on the development of the atherosclerotic lesions. Analysis of circulating fatty acids and inflammatory factors were measured and flow cytometry was conducted on plasma and lysed spleen and bone marrow to assess proportions of immune cells. Result(s): Blood levels of EPA and DHA were increased compared to control. EPA reduced circulating pro-inflammatory arachidonic acid (P<0.0001) and omega-6, leading to reduced omega-6:omega-3 ratio (P<0.0001). Plaque burden was similar in all mice, yet fibrous cap thickness, was increased in mice treated with EPA (0.0068 +/- 0.0014). Conclusion(s): This study supports the concept that EPA may have an atheroprotective role by lowering inflammatory signalling and thereby increasing plaque stability.Copyright © 2024 | Conference Name: | EAS 2024 | Conference Start Date: | 2024-07-01 | Conference End Date: | 2024-07-05 | Conference Location: | Padova, Italy | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.atherosclerosis.2024.117742 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/52328 | Type: | Conference Abstract | Subjects: | atherosclerosis bone marrow carotid artery disease carotid atherosclerotic plaque carotid stenosis cholesterol diet flow cytometry right common carotid artery spleen |
Appears in Collections: | Conferences |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.